» Articles » PMID: 16562584

Weight Gain in Craniopharyngioma--a Model for Hypothalamic Obesity

Overview
Date 2006 Mar 28
PMID 16562584
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To evaluate (1) the pattern of post-operative weight gain and (2) the risk factors associated with the development of post-operative weight gain and obesity in children treated for craniopharyngioma.

Study Design: The records of 43 children who had primary craniopharyngioma resection were reviewed. Neurological, endocrine, anthropometric and radiological risk factors for the development of obesity and for post-operative increase in BMI SDS were analyzed.

Results: Twenty-five patients (58%) became obese post-operatively. Obesity was significantly associated with higher BMI SDS at presentation and pre-operative hydrocephalus (p < 0.05). Increased BMI SDS from 0-12 months was significantly associated with post-operative MRI evidenced hypothalamic damage and higher BMI at presentation (p < 0.05).

Conclusions: Children who developed hypothalamic obesity had a significant, rapid BMI increase over the first 6 months, followed by stabilization, with no regression of BMI SDS.

Citing Articles

Treatment of Hypothalamic Obesity With GLP-1 Analogs.

Dimitri P, Roth C J Endocr Soc. 2024; 9(1):bvae200.

PMID: 39703362 PMC: 11655849. DOI: 10.1210/jendso/bvae200.


Obesity in patients with craniopharyngioma in the South Asian region - A distinct phenotype.

Tatachar S, Rajan R, Hesaraghatta Shyamsunder A, Kapoor N Obes Pillars. 2024; 12:100139.

PMID: 39431051 PMC: 11489328. DOI: 10.1016/j.obpill.2024.100139.


Special considerations for the child with obesity: An Obesity Medicine Association (OMA) clinical practice statement (CPS) 2024.

Cuda S, Censani M, OHara V, Paisley J, Kharofa R, Conroy R Obes Pillars. 2024; 11:100113.

PMID: 38953014 PMC: 11216014. DOI: 10.1016/j.obpill.2024.100113.


Exploration of the shared pathways and common biomarker in adamantinomatous craniopharyngioma and type 2 diabetes using integrated bioinformatics analysis.

Han Y, Wang Y, Li S, Sato K, Yamagishi S PLoS One. 2024; 19(6):e0304404.

PMID: 38848397 PMC: 11161051. DOI: 10.1371/journal.pone.0304404.


Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon.

Roth C, Zenno A Front Endocrinol (Lausanne). 2023; 14:1256514.

PMID: 37780616 PMC: 10533996. DOI: 10.3389/fendo.2023.1256514.